A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder-Reference-Cited by-同舟云学术

A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder

Published:2012-01 Issue:1 Volume:163 Page:27-32
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

White William B.,Grady Deborah,Giudice Linda C.,Berry Scott M.,Zborowski Joanne,Snabes Michael C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Sexual dysfunction in the United States: prevalence and predictors;Laumann;JAMA,1999

2. Sexual problems and distress in United States women: prevalence and correlates;Shifren;Obstet Gynecol,2008

3. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women;West;Arch Intern Med,2008

4. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial;Buster;Obstet Gynecol,2005

5. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder;Simon;J Clin Endocrinol Metab,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual Desire and Pharmacologic Management;Obstetrics and Gynecology Clinics of North America;2024-06

2. Clinical management of androgen excess and defect in women;Expert Review of Endocrinology & Metabolism;2023-11-12

3. What is the Role of Testosterone Therapy in Postmenopausal Women? A SWOT Analysis;Clinical and Experimental Obstetrics & Gynecology;2023-08-02

4. Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?;Pharmaceuticals;2023-04-20

5. Testosterone Therapy in Women;Obstetrics & Gynecology;2021-10-06